Exelixis, Inc.
Biotechnology company · Alameda, California, United States · Nasdaq: EXEL
Exelixis, Inc. is a biotechnology company headquartered in Alameda, California, United States. Its shares trade on Nasdaq under the ticker EXEL.
Profile compiled from public records. Is this your company? Request a correction or update
Exelixis at a glance
Typebiotechnology company
HeadquartersAlameda, California, United States
Stock listingNasdaq: EXEL
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK939767
What does Exelixis do?
Frequently asked questions about Exelixis
Where is Exelixis headquartered?
Exelixis, Inc. is headquartered in Alameda, California, United States.
What does Exelixis do?
Exelixis, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Exelixis a public company?
Yes. Exelixis, Inc. trades on Nasdaq under the ticker EXEL.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.